KRISTEN BLACKWELL: Open Payments
NPI 1144624933 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 11 companies in 2025. Trend: 2023 $356 · 2024 $263 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Medtronic, Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Novo Nordisk Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, LEQVIO, PROPEL, Rybelsus, JARDIANCE, AIRSUPRA, INCEPTIV, SHINGRIX.
Industry payments across TX — which companies pay providers there.
